Boston Family Office’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-2,025
Closed -$338K 268
2018
Q2
$338K Sell
2,025
-2,822
-58% -$453K 0.04% 224
2018
Q1
$816K Buy
4,847
+225
+5% +$37.7K 0.09% 157
2017
Q4
$756K Buy
4,622
+500
+12% +$89.7K 0.08% 167
2017
Q3
$845K Sell
4,122
-1,050
-20% -$244K 0.1% 157
2017
Q2
$1.26M Sell
5,172
-880
-15% -$207K 0.15% 138
2017
Q1
$1.45M Sell
6,052
-490
-7% -$114K 0.18% 126
2016
Q4
$1.37M Buy
6,542
+1,140
+21% +$236K 0.18% 125
2016
Q3
$1.24M Sell
5,402
-540
-9% -$132K 0.16% 134
2016
Q2
$1.37M Sell
5,942
-2,561
-30% -$590K 0.18% 125
2016
Q1
$2.28M Buy
8,503
+1,380
+19% +$395K 0.3% 97
2015
Q4
$2.23M Buy
7,123
+70
+1% +$20.8K 0.3% 96
2015
Q3
$1.92M Buy
7,053
+690
+11% +$212K 0.27% 101
2015
Q2
$1.93M Buy
6,363
+454
+8% +$135K 0.24% 106
2015
Q1
$1.76M Buy
5,909
+2,952
+100% +$842K 0.22% 111
2014
Q4
$761K Hold
2,957
0.09% 165
2014
Q3
$713K Buy
+2,957
New +$662K 0.09% 171

Other funds holding AGN

Boston Family Office's AGN Position: Q3 2018 in Review

Boston Family Office sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 2,025 shares — an estimated $338K sold.

Boston Family Office first reported a position in AGN in Q3 2014 and held it in 16 quarters. The position peaked at $2.28M in Q1 2016. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Boston Family Office reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • Boston Family Office sold 2,025 Allergan plc shares in Q3 2018, an estimated $338K.
  • Boston Family Office first reported a position in Allergan plc in Q3 2014 and held it in 16 quarters.
  • Boston Family Office's Allergan plc position peaked at $2.28M in Q1 2016.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Boston Family Office's 13F filing for Q3 2018, filed 1 Nov 2018.